Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

about

Role of noninvasive molecular imaging in determining response

P2860

Q58119177-8BADFEA1-3EAF-4DEC-8C18-0F51052F1BD4

P2860

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

Item

http://www.wikidata.org/entity/Q52655396

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@en

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@nl

type

Item

label

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@en

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@nl

prefLabel

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@en

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@nl

P1476

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

@en

P2093

Celia Cook

http://www.w3.org/2001/XMLSchema#string

Jane Sosabowski

http://www.w3.org/2001/XMLSchema#string

Julie Foster

http://www.w3.org/2001/XMLSchema#string

Nia Emami-Shahri

http://www.w3.org/2001/XMLSchema#string

Patrycja Gazinska

http://www.w3.org/2001/XMLSchema#string

Roxana Kashani

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human sodium lodide symporter

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies

Chimeric antigen receptor T cells for sustained remissions in leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

P2888

s41467-018-03524-1

P304

1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03524-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Papa

John Maher

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101481580

http://www.w3.org/2001/XMLSchema#string

P698

29540684

http://www.w3.org/2001/XMLSchema#string

P932

5852048

http://www.w3.org/2001/XMLSchema#string

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

about

P2860

P2860

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932